Key Roles and Responsibilities. The Authority will nominate a Grant Sponsor who will work with the Scheme Manager to monitor the delivery of the agreed Purpose and act as the principal point of contact. Their name and contact details are recorded in Xxxxx X.
Key Roles and Responsibilities. Responsibilities University District Other Other
Key Roles and Responsibilities. 37.4.1. The Service Provider shall be required to ensure that it at all times has a succession plan per Key Employee Function so as to carry out the relevant functions in providing the Services, each successor with the requisite skill levels and/or qualifications required for fulfilling the requirements of that Key Employee Function.
Key Roles and Responsibilities. In accordance with NHS Screening Programmes’ standards and protocols the provider will ensure that the following roles are fulfilled: Clinical Lead Programme Manager Senior Screener/Grader Screener/Grader Failsafe Officer Administrator The Provider is responsible for providing Clinical Leadership, The Clinical Lead has overall clinical responsibility and professional accountability for the Programme across the pathway. The Clinical Lead (CLDESP) will either be a consultant (or senior specialty doctor) ophthalmologist with medical retina experience or a consultant diabetologist. In many programmes, the CLDESP is also the ophthalmology lead for DR at one of the HES/treatment centres but this is not a requirement. If the CLDESP is a consultant diabetologist then a consultant or senior specialty doctor grade ophthalmologist with medical retina experience should be appointed to provide dedicated support to the programme. The detailed responsibilities of the Clinical Lead are set out in section 3.5 below. The Provider is responsible for providing Programme Management. The programme manager has overall responsibility for the operational running of all aspects of the programme including its quality assurance processes and for implementing continuous improvement strategies. The detailed responsibilities of the Programme Manager are set out in section 3.4 below. The Provider is responsible for providing a senior screener/grader. The senior screener/grader will be clinically responsible to the clinical lead. The senior screener/grader will be an experienced grader who supervises and provides training and feedback to the programme’s team of screeners and graders and ensures that all members of the screening and grading team meet national standards. This role may be undertaken by the clinical lead or be delegated to the programme manager or an accredited screener/grader. The Provider is responsible for providing an appropriate number of screeners and graders to ensure that all eligible people with diabetes in its cohort can be screened and graded according to national standards. Grading must be provided at primary, secondary, arbitration and referral outcome grade levels. The responsibilities of the screener include: explaining the test procedure to the person with diabetes and obtaining consent; undertaking visual acuity checks, instilling eye drops, taking digital images. The responsibilities of the grader include: grading each digital image according to ...
Key Roles and Responsibilities. The Accredited Provider Trainee Entitlement whilst on placement
Key Roles and Responsibilities. The Authority will nominate a Grant Sponsor who will work with the Recipient’s Project Manager to monitor the delivery of the agreed Purpose and act as the principal point of contact. Their name and contact details are recorded in Annex C.
Key Roles and Responsibilities. Subject to the development plan set forth in Section 2.2:
(a) Chugai shall provide ArTara with access to the Chugai Materials and provide technical support during the Chugai Service Period, to the extent requested by ArTara and deemed reasonably necessary by Chugai for ArTara’s use in the development and commercialization of the New Product. During the Chugai Service Period, Chugai shall not provide Existing Product or Chugai Materials to any Third Parties other than for medical, compassionate use and/or non-commercial research purposes. Further, during the period from the Effective Date until (x) fifth anniversary of the Effective Date or (y) this Agreement is terminated by Chugai for a material breach or default by ArTara in accordance with Section 8.4(a), insolvency, etc. of ArTara in accordance with Section 8.4(b) or Change of Control in accordance with Section 8.4(c), whichever comes earlier, Chugai shall not provide Chugai Materials or technical support to any Third Party for the purpose of the development and commercialization in the ArTara Territory of a therapeutic product comparable to the Existing Product;
(b) ArTara shall be solely responsible, at its sole cost and expense, for the development and commercialization of the New Product in the ArTara Territory (including obtaining and maintaining of required licenses and approvals for the New Product, communication and negotiation with the FDA and other relevant Regulatory Authorities, manufacturing, sales and marketing of the New Product); and shall give Chugai access, free of charge, to all information, data (including pre-clinical, clinical and manufacturing data), documentation, materials and know-how related to the New Product that are owned or controlled by ArTara, to the extent reasonably necessary for Chugai to (x) complete the Site Transfer for the Existing Product and partial change application therefor in the Chugai Territory and (y) maintain the Marketing Authorization of the Existing Product in the Chugai Territory. Such development and commercialization of the New Product by ArTara shall be aimed toward securing a product comparable to the Existing Product that will satisfy Japanese and Taiwanese regulatory requirements for Chugai to complete the Site Transfer for the Existing Product. ArTara shall not use or permit any Third Parties to use the Chugai Service Deliverables for any purpose other than such development and commercialization of the New Product;
(c) Chugai shall perform an...
Key Roles and Responsibilities. Responsibilities Preparation program District Other Other
Key Roles and Responsibilities. INTERNAL
(a) The parties shall appoint the following persons to act in the roles described in this paragraph 2.3 and attend the relevant meetings, on and from the Restatement Date. Further persons/roles relating to a particular Country shall be set out in the relevant Local Services Agreement, as applicable.
(b) The parties shall ensure that their respective representatives in the governance model are empowered and authorised to resolve the issues before them. An HSBC representative will chair each of the governance meetings.
(i) HSBC Roles and Responsibilities [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***]
(ii) Supplier Roles and Responsibilities The persons occupying the Supplier roles set out in the table below (and in relation to a specific Country, as may be set out in the relevant Local Services Agreement) shall be considered Key Personnel. INTERNAL [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***]
Key Roles and Responsibilities. The governing board is responsible for:
2.1. Implementing effective policies and procedures are in place to ensure that pupils are kept safe from alcohol and drugs at school.
2.2. Ensuring that the Drug and Alcohol Policy is maintained and disseminated to all staff.
2.3. Ensuring that pupils experiencing difficulties with alcohol and/or drugs (themselves or within their families) can access the support they need.
2.4. Working with the headteacher, and in liaison with parents, pupils, health and other professionals, to ensure that the drug and alcohol curriculum addresses the needs of pupils and the local community, and reflects current trends.
2.5. Ensuring that the designated safeguarding governor submits an annual written report to the governing board concerning drug and alcohol related incidents and concerns.
2.6. The day-to-day management of this policy.
2.7. Providing a safe environment for all staff, pupils and visitors.
2.8. Working with governors to ensure compliance with relevant legislation.
2.9. Informing the governing board, via the designated safeguarding governor, of any issues and developments concerning drugs and alcohol.
2.10. Acting on any concerns arising from pupils’ use of drugs and alcohol.
2.11. If appropriate, and where doing so will not place the child at risk, informing parents of any drug and alcohol related incidents concerning their child.
2.12. Inviting the local police and drugs team into school to raise awareness of the risks and issues associated with drugs.
2.13. Informing the police of any drug or alcohol related decision, where they deem it appropriate to do so.
2.14. Ensuring a consistent approach to managing drug and alcohol incidents.
2.15. Ensuring that staff have the skills to teach and discuss issues relating to drugs and alcohol.
2.16. Ensuring that staff and pupils experiencing difficulties with drugs or alcohol are provided with appropriate internal support and referred to external support agencies as appropriate.
2.17. Consulting with pupils to inform provision around drugs and alcohol education.
2.18. Accessing appropriate training to enable them to successfully advise the school on drug and alcohol matters.
2.19. Liaising with local services as necessary to provide support for pupils.
2.20. Assisting with the monitoring and review of this policy.
2.21. Ensuring they do not bring illegal or prohibited drugs or alcohol onto school premises or whilst engaged in any offsite activity representing the school.
2.22....
